Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

<< Previous

Bullboard Posts

Next >>

Post by edroseon Oct 20, 2019 9:21am

49 Views

Post# 30248474

They did massive reverse split at a time when conf

Confidence was very low,they have amf investigating their actions and retail investors suing them an rcmp file No wonder the sp dropped significantly. That was very bad decision

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario